Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/26244
Title: | Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials | Authors: | Wijns, William VROLIX, Mathias Verheye, Stefan Schoors, Danny Slagboom, Ton Gosselink, Marcel BENIT, Edouard Kandzari, David Donohoe, Dennis Ormiston, John |
Issue Date: | 2018 | Source: | EUROINTERVENTION, 13(18), p. E2147-E2151 | Abstract: | Aims: The aim of this study was to evaluate the five-year clinical results of a sirolimus-eluting stent (MiStent SES) with a bioabsorbable coating designed for sustained drug delivery during and after rapid polymer dissolution. Methods and results: The five-year results from the DESSOLVE I and II trials including major adverse cardiac events (MACE), target lesion failure (TLF), target vessel failure (TVF), and stent thrombosis (ST) at five-year follow-up are reported. In DESSOLVE I, 10.3% of patients receiving the MiStent SES (3/29) had a MACE event up to five years without TLF. In DESSOLVE II, 15.1% of patients in the MiStent group (18/119) had a five-year MACE event compared to 22.0% of patients in the Endeavor group (p= 0.295). TLF was 9.2% in the MiStent group and 8.5% in the Endeavor group (p= 1.00). TVF was 10.1% for MiStent versus 15.3% for Endeavor (p= 0.331). Up to five-year follow-up, the MiStent SES has continued to demonstrate low rates of TLR across DESSOLVE I (0.0%) and DESSOLVE II (3.4%). No ST was reported with the MiStent up to five years in the DESSOLVE I trial. In DESSOLVE II, definite or probable ST was 0.0% with MiStent and 1.7% with Endeavor up to five years. Conclusions: The MiStent SES demonstrated long-term safety and effectiveness with low rates of fiveyear MACE, TLF, and TVF across these two clinical trials. | Notes: | Wijns, W (reprint author), Natl Univ Ireland Galway, Lambe Inst Translat Med, Floor 2,Univ Rd, Galway H91 TK33, Ireland. William.Wyns@nuigalway.ie | Keywords: | clinical research; clinical trials; drug-eluting stent; multiple vessel disease; single vessel disease | Document URI: | http://hdl.handle.net/1942/26244 | ISSN: | 1774-024X | e-ISSN: | 1969-6213 | DOI: | 10.4244/EIJ-D-17-00230 | ISI #: | 000430649300013 | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Show full item record
SCOPUSTM
Citations
4
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
14
checked on Oct 10, 2024
Page view(s)
110
checked on Jun 28, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.